Chemoinformaics analysis of Dehydrocycloatalantin
| Molecular Weight | 466.486 | nRot | 1 |
| Heavy Atom Molecular Weight | 440.278 | nRig | 35 |
| Exact Molecular Weight | 466.163 | nRing | 7 |
| Solubility: LogS | -4.904 | nHRing | 4 |
| Solubility: LogP | 1.92 | No. of Aliphatic Rings | 6 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 60 | No. of Aliphatic Hetero Cycles | 3 |
| No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 0 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 2 |
| No. of Hydrogen atom | 26 | No. of Saturated Hetero Cycles | 3 |
| No. of Carbon atom | 26 | No. of Saturated Rings | 5 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 5 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 5 |
| nHA | 8 | APOL | 67.1726 |
| nHD | 0 | BPOL | 36.4994 |
| QED | 0.269 |
| Synth | 5.914 |
| Natural Product Likeliness | 2.827 |
| NR-PPAR-gamma | 0.612 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.982 |
| Pgp-sub | 0 |
| HIA | 0.02 |
| CACO-2 | -5.393 |
| MDCK | 0.0000184 |
| BBB | 0.257 |
| PPB | 0.766527 |
| VDSS | 1.218 |
| FU | 0.214787 |
| CYP1A2-inh | 0.014 |
| CYP1A2-sub | 0.967 |
| CYP2c19-inh | 0.178 |
| CYP2c19-sub | 0.707 |
| CYP2c9-inh | 0.359 |
| CYP2c9-sub | 0.016 |
| CYP2d6-inh | 0.015 |
| CYP2d6-sub | 0.055 |
| CYP3a4-inh | 0.766 |
| CYP3a4-sub | 0.848 |
| CL | 6.978 |
| T12 | 0.179 |
| hERG | 0.032 |
| Ames | 0.355 |
| ROA | 0.983 |
| SkinSen | 0.101 |
| Carcinogencity | 0.953 |
| EI | 0.02 |
| Respiratory | 0.963 |
| NR-Aromatase | 0.786 |
| Antiviral | Yes |
| Prediction | 0.79625 |